Treatment of upper limb deep vein thrombosis with low molecular weight heparin

被引:2
|
作者
Shah, MK [1 ]
Black-Schaffer, RM [1 ]
机构
[1] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA
关键词
upper extremity; deep vein thrombosis; treatment; low molecular weight heparin;
D O I
10.1097/01.PHM.0000064740.19570.2A
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Upper limb deep vein thrombosis has been an under-recognized disease; however, physicians' awareness of it as a cause of arm pain and edema is increasing. Previously thought of as benign, upper limb deep vein thrombosis has been shown in recent studies to pose a significant risk for pulmonary embolus and death. The need for treatment is now recognized; however, effective treatments for upper limb deep vein thrombosis have not been fully defined. Anticoagulation with oral agents is known to be successful in preventing complications and recurrence. This report presents the first case of upper limb deep vein thrombosis successfully treated with only low molecular weight heparin.
引用
收藏
页码:415 / 417
页数:3
相关论文
共 50 条
  • [21] Workshop: Implementation of home treatment programs for deep vein thrombosis with low molecular weight heparin
    Kwong, NM
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 9 (01) : S53 - S54
  • [22] Deep vein thrombosis (DVT) in childhood: Treatment with low-molecular-weight heparin (LMWH)
    Aversa, L
    Vazquez, A
    Bustelo, P
    THROMBOSIS AND HAEMOSTASIS, 1999, : 200 - 200
  • [23] Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin
    Harrison, L
    McGinnis, J
    Crowther, M
    Ginsberg, J
    Hirsh, J
    ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (18) : 2001 - 2003
  • [24] Workshop: Implementation of Home Treatment Programs for Deep Vein Thrombosis with Low Molecular Weight Heparin
    Norman M. Kwong
    Journal of Thrombosis and Thrombolysis, 2000, 9 (Suppl 1) : 53 - 54
  • [25] INTRAVENOUS LOW-MOLECULAR-WEIGHT HEPARIN VS HEPARIN FOR THE INITIAL TREATMENT OF DEEP-VEIN THROMBOSIS
    MERLI, G
    COMP, P
    ELLIOTT, G
    ROSSI, M
    TROY, S
    HOLLOWAY, S
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1117 - 1117
  • [26] Cost-effectiveness of low-molecular weight heparin and unfractionated heparin in treatment of deep vein thrombosis
    Rodger, M
    Bredeson, C
    Wells, PS
    Beck, J
    Kearns, B
    Huebsch, LB
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1998, 159 (08) : 931 - 938
  • [27] Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis
    Harenberg, J
    Stehle, G
    Blauth, M
    Huck, K
    Mall, K
    Heene, DL
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (01): : 83 - 90
  • [28] To Compare the Effectiveness of Low-Molecular-Weight Heparin and Unfractionated Heparin in Reducing Lower Limb Girth in Deep Vein Thrombosis
    Ullalkar, Neha
    Vedanth, M.
    Sreeramulu, P. N.
    Vaibhavi, D.
    Shashirekha, C. A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [29] LOW-MOLECULAR WEIGHT HEPARIN AND POSTOPERATIVE DEEP-VEIN THROMBOSIS
    KAKKAR, VV
    DJAZAERI, B
    WEBB, P
    SCULLY, M
    WESTWICK, J
    MACGREGOR, I
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 116 - 116
  • [30] Low-molecular-weight heparin in patients with deep-vein thrombosis
    Stricker, H
    Mombelli, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (04): : 292 - 293